Strength
1000 ug/mL
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310662702
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/18/2025
Active Ingredients
PRAMLINTIDE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA021332On Market Since
1/8/2015
Pharmacological Classes
Amylin Agonists
Amylin Analog
Related Drugs
Same classification
No related drugs found.